Identification of distinct signalling pathways for somatostatin receptors SSTR1 and SSTR2 as revealed by microphysiometry

被引:8
|
作者
Chen, LC
Tashjian, AH
机构
[1] Harvard Sch Publ Hlth, Dept Canc Cell Biol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
关键词
somatostatin receptor; signalling pathway; microphysiometry;
D O I
10.1016/S0898-6568(99)00019-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Somatostatin receptors (SSTRs) are known to mediate diverse cellular responses. Most target cells express more than one SSTR isoform, making it difficult to define the signalling pathway used by individual receptor subtypes, Thus, we have expressed SSTR1 or SSTR2 in rat pituitary F4C1 cells which lack endogenous SSTRs. Using a silicon-based biosensor system, the Cytosensor microphysiometer, which measures the extracellular acidification rate (ECAR) in real time, we have studied the responses to SS mediated by either SSTR1 or SSTR2. In control F4C1 cells, SS had no effect on the basal ECAR. In transfected cells expressing only SSTR1, SS caused a unique decrease in ECAR in a concentration-dependent manner. Receptor-mediated decreases in ECAR have not been reported previously. In F4C1 cells expressing only SSTR2, SS induced a bidirectional ECAR response, a rapid increase followed by a decrease below basal. Two SS analogues, MK678 and CH275, induced characteristic ECAR responses with the expected receptor selectivities for SSTR1 or SSTR2. Pretreatment of F4C1 cells with pertussis toxin abolished the decreases in ECAR mediated by both SSTR1 and SSTR2, but only partially reduced the increase in ECAR mediated by SSTR2. The decrease in ECAR did not depend on a decrease in intracellular cAMP. The ECAR responses to SS were modestly attenuated by methylisobutylamiloride (MIA), an inhibitor of the ubiquitous Na+-H+ exchanger NHE1. Removal of extracellular Na+ greatly inhibited the ECAR responses to SS, demonstrating a role for both amiloride sensitive and -insensitive Na+-dependent acid transport mechanisms in SS induced extracellular acidification. In conclusion, we have identified and characterized different signalling pathways for SSTR1 and SSTR2 in pituitary cells as measured by crophysiometry. (C) 1999 Elsevier Science Inc.
引用
下载
收藏
页码:499 / 505
页数:7
相关论文
共 50 条
  • [21] Somatostatin Receptor Type 2 (SSTR2) in Bronchopulmonary Carcinoids
    Fassan, Matteo
    Rea, Federico
    Clemente, Roberto
    Rizzardi, Giovanna
    Pizzi, Marco
    Giacomelli, Luciano
    Rugge, Massimo
    ENDOCRINE PATHOLOGY, 2010, 21 (03) : 204 - 205
  • [22] Somatostatin Receptor Type 2 (SSTR2) in Bronchopulmonary Carcinoids
    Matteo Fassan
    Federico Rea
    Roberto Clemente
    Giovanna Rizzardi
    Marco Pizzi
    Luciano Giacomelli
    Massimo Rugge
    Endocrine Pathology, 2010, 21 : 204 - 205
  • [23] EXPRESSION OF SSTR1 AND SSTR2 IN RAT HYPOTHALAMUS - CORRELATION WITH RECEPTOR-BINDING AND DISTRIBUTION OF GROWTH-HORMONE REGULATORY PEPTIDES
    BEAUDET, A
    TANNENBAUM, GS
    SOMATOSTATIN AND ITS RECEPTORS, 1995, 190 : 142 - 152
  • [24] IMMUNOLOGICAL DETECTION OF ISOFORMS OF THE SOMATOSTATIN RECEPTOR SUBTYPE, SSTR2
    THEVENIAU, MA
    YASUDA, K
    BELL, GI
    REISINE, T
    JOURNAL OF NEUROCHEMISTRY, 1994, 63 (02) : 447 - 455
  • [25] DETECTION OF SOMATOSTATIN RECEPTOR SUBTYPE-2 (SSTR2) IN ESTABLISHED TUMORS AND TUMOR-CELL LINES - EVIDENCE FOR SSTR2 HETEROGENEITY
    TAYLOR, JE
    THEVENIAU, MA
    BASHIRZADEH, R
    REISINE, T
    EDEN, PA
    PEPTIDES, 1994, 15 (07) : 1229 - 1236
  • [26] Overexpression of SSTR2 inhibited the growth of SSTR2-positive tumors via multiple signaling pathways
    Zhou, Tianhong
    Xiao, Xiaoping
    Xu, Bin
    Li, Hongjian
    Zou, Yi
    ACTA ONCOLOGICA, 2009, 48 (03) : 401 - 410
  • [27] SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells
    Kailey, Balrik
    van de Bunt, Martijn
    Cheley, Stephen
    Johnson, Paul R.
    MacDonald, Patrick E.
    Gloyn, Anna L.
    Rorsman, Patrik
    Braun, Matthias
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2012, 303 (09): : E1107 - E1116
  • [28] Somatostatin receptor imaging in mice with different positive rate of SSTR2
    Xie, Q.
    Meng, X.
    Yang, Z.
    Yu, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S460 - S460
  • [29] Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1)
    Florio, T
    Yao, H
    Carey, KD
    Dillon, TJ
    Stork, PJS
    MOLECULAR ENDOCRINOLOGY, 1999, 13 (01) : 24 - 37
  • [30] A microplate binding assay for the somatostatin type-2 receptor (SSTR2)
    Froidevaux, S
    Meier, M
    Häusler, M
    Mäcke, H
    Beglinger, C
    Eberle, AN
    JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1999, 19 (1-4): : 167 - 180